相关实验视频

Updated: Jun 3, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

在质母细胞瘤中微RNA和KRAS之间的相互作用

Ozal Beylerli¹, Elmar Musaev², Gervith Reyes Soto³

¹Central Research Laboratory, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 3 Lenin Street, 450008, Russia.

Current medicinal chemistry

|January 8, 2025

概括

这项研究探讨了基斯鼠肉瘤病毒 (KRAS) 和质母细胞瘤 (GBM) 中的微RNA (miRNA) 之间的复杂关系. 了解这种联系可能会为这种侵袭性脑癌带来新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
基因突变基因基因基因基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变基因突变
微RNAs (miRNAs) 正在成为KRAS信号通路中的关键调节者.

研究的目的:

为了研究KRAS和miRNAs在GBM中的相互作用.
探索KRAS信号如何影响miRNA表达,反之亦然.
检查这种相互作用在瘤基因诱导衰老 (OIS) 和瘤进展中的作用.

主要方法:

确定针对KRAS mRNA的特定miRNAs.
分析受KRAS和miRNAs影响的下游信号级联.
研究KRAS激活路径和miRNA水平之间的反循环.

主要成果:

确定了某些直接向KRAS的miRNAs.
建立了一个反循环,其中KRAS激活调节特定的miRNA水平.
这些相互作用与绕过瘤基因诱导衰老 (OIS) 有关.

结论:

这种miRNA-KRAS连接是GBM中关键的分子机制.
这种相互作用影响细胞调节,生存和瘤进展.
针对miRNA-KRAS轴为创新的GBM疗法提供了潜在的途径.

关键词:

在GBMGBMGBMGBMGBM 这种基因是KRAS基因.气流的产生是气流的产生.这是一个小RNARNA.目标,目标,目标.治疗疗法治疗疗法治疗疗法

更多相关视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...